China-US Relations

Why China’s biotech rise is harder to contain than AI

China is emerging as a biotech powerhouse, but its rise is entwined with US drugmakers through research, licensing and supply chains, making decoupling far more difficult than in AI. Academic Chen Xiangming and biopharma industry practitioner Leon Tang analyse the situation.

Chen Xiangming, Leon Tang

05 Aug 2026

China’s real space race is not against SpaceX

China’s recovery of a Long March 10B orbital-class rocket booster shows it is starting to achieve reusability. Once it can launch satellites at lower cost and replicate it, it can control the orbital economy, observes technopreneur Akhmad Hanan.

Akhmad Hanan

22 Jul 2026

As China moves forward, America turns backward and inward

Comparing the US and Chinese presidents’ recent narratives, it is clear that China keeps moving forward as a confident global leader, while an insecure Trump is taking America backward, says US academic Zhiqun Zhu.

Zhiqun Zhu

21 Jul 2026

How geopolitics rewired China’s economy

Looking beyond the numbers of China’s published half-year economic data, it is clear that structural changes in China’s economy are taking place, which will have broader effects in the longer term, says academic Gu Qingyang.

Gu Qingyang

15 Jul 2026

US’s biotech scrutiny tests China’s drugmakers abroad

A proposed US bill to tighten scrutiny of biotech investment in China is casting a shadow over cross-border drug licensing, threatening a fast-growing partnership model that has fuelled innovation and global drug development.

Caixin Global

10 Jul 2026

America’s 250-year strategy meets China’s rise

For 250 years, US grand strategy has been built on preventing any rival from dominating Europe or Asia. China’s rise has ended America’s uncontested primacy in East Asia, forcing Washington to rethink how it can preserve its security and influence. US academic Robert S. Ross gives his assessment.

Robert S. Ross

08 Jul 2026

China’s G2 reality and Hormuz’s new normal

As the world increasingly sees China and the US as a de facto G2, experts debate China’s global role while warning of a new normal in the Strait of Hormuz. Lianhe Zaobao China news correspondent Edwin Ong highlights key takeaways from the eighth Singapore-China Forum.

Edwin Ong

07 Jul 2026

What China really wants from global governance

Behind China’s new global governance white paper lies a broader ambition: to reshape international rules and institutions to reflect Beijing’s growing power and influence, says commentator Deng Yuwen.

Deng Yuwen

07 Jul 2026

The Taiwan trigger that could break Trump’s China truce

Chinese and American experts agree that US-China ties have stabilised under Donald Trump, but warn the calm may prove temporary. Taiwan, economic decoupling and America’s political cycle could determine whether the fragile truce survives beyond Trump’s presidency. Lianhe Zaobao associate China news editor Sim Tze Wei reports from Beijing.

Sim Tze Wei

06 Jul 2026

Trump’s China thaw will hit a Washington wall

Try as US President Trump might to build a stronger bridge to China in the name of deal-making, bipartisan consensus in Congress against the China threat will likely keep him in check, says US academic Robert Sutter.

Robert Sutter

02 Jul 2026

Undersea cables: The new US-China frontline

From trade wars to the seabed, Washington and Beijing are locked in a high-stakes struggle for control over global undersea cables and leadership of the future digital order. Lianhe Zaobao associate China news editor Sim Tze Wei looks into the matter.

Sim Tze Wei

24 Jun 2026

What SpaceX’s IPO means for China

While the SpaceX IPO may spur greater Chinese investment in AI-related high technology, it could also lead to side effects like speculative bubbles. Meanwhile, with national security politics overriding commercial pragmatism, China may increasingly be at a disadvantage. EAI senior research fellow Bo Chen analyses the situation.

Bo Chen

15 Jun 2026